<DOC>
	<DOCNO>NCT02964728</DOCNO>
	<brief_summary>The effect botulinum neurotoxin type A intradermal injection evaluate 4 patient clinical diagnosis burn mouth syndrome involve anterior two-thirds tongue low lip least 6 month , refractory common pharmacological treatment . Pain severity measure visual analog scale ( VAS ) indicate average week pain injection . Each patient inject total dose 16 unit ( dilution : 2 ml saline ) incobotulinumA : 4 unit side low lip 4 unit antero-lateral side tongue . In order determine placebo effect may involve , inject 2 additional patient saline solution use volume injection site . Patients evaluate 48 hour 4 , 8 , 12 , 16 20 week treatment . Patients treat placebo treat 4 week incobotulinumA dose report .</brief_summary>
	<brief_title>Botulinum Toxin Burning Mouth Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Burns</mesh_term>
	<mesh_term>Burning Mouth Syndrome</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>burn mouth syndrome mouth disorder</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>